In-vivo activity of IFN-λ and IFN-α against bovine-viral-diarrhea virus in a mouse model

Bovine-viral-diarrhea virus (BVDV) can cause significant economic losses in livestock. The disease is controlled with vaccination and bovines are susceptible until vaccine immunity develops and may remain vulnerable if a persistently infected animal is left on the farm; therefore, an antiviral agent that reduces virus infectivity can be a useful tool in control programs. Although many compounds with promising in-vitro efficacy have been identified, the lack of laboratory-animal models limited their potential for further clinical development. Recently, we described the activity of type I and III interferons, IFN-α and IFN-λ respectively, against several BVDV strains in-vitro. In this study, we analyzed the in-vivo efficacy of both IFNs using a BALB/c-mouse model. Mice infected with two type-2 BVDV field strains developed a viremia with different kinetics, depending on the infecting strain's virulence, that persisted for 56 days post-infection (dpi). Mice infected with the low-virulence strain elicited high systemic TNF-α levels at 2 dpi. IFNs were first applied subcutaneously 1 day before or after infection. The two IFNs reduced viremia with different kinetics, depending on whether either one was applied before or after infection. In a second experiment, we increased the number of applications of both IFNs. All the treatments reduced viremia compared to untreated mice. The application of IFN-λ pre- and post-infection reduced viremia over time. This study is the first proof of the concept of the antiviral potency of IFN-λ against BVDV in-vivo, thus encouraging further trails for a potential use of this cytokine in cattle.

Saved in:
Bibliographic Details
Main Authors: Quintana, Maria Eugenia, Barone, Lucas Jose, Trotta, Myrian Vanesa, Turco, Cecilia Soledad, Mansilla, Florencia Celeste, Capozzo, Alejandra, Cardoso, Nancy
Format: info:ar-repo/semantics/artículo biblioteca
Language:eng
Published: Frontiers Media 2020-02
Subjects:Bovine Diarrhoea Pestivirus, Interferons, Antiviral Agents, Pestivirus de la Diarrea Bovina, Interferonas, Viricidas, Mouse Model, Modelo de Ratón,
Online Access:http://hdl.handle.net/20.500.12123/8606
https://www.frontiersin.org/articles/10.3389/fvets.2020.00045/full
https://doi.org/10.3389/fvets.2020.00045
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:localhost:20.500.12123-8606
record_format koha
spelling oai:localhost:20.500.12123-86062021-01-15T15:21:46Z In-vivo activity of IFN-λ and IFN-α against bovine-viral-diarrhea virus in a mouse model Quintana, Maria Eugenia Barone, Lucas Jose Trotta, Myrian Vanesa Turco, Cecilia Soledad Mansilla, Florencia Celeste Capozzo, Alejandra Cardoso, Nancy Bovine Diarrhoea Pestivirus Interferons Antiviral Agents Pestivirus de la Diarrea Bovina Interferonas Viricidas Mouse Model Modelo de Ratón Bovine-viral-diarrhea virus (BVDV) can cause significant economic losses in livestock. The disease is controlled with vaccination and bovines are susceptible until vaccine immunity develops and may remain vulnerable if a persistently infected animal is left on the farm; therefore, an antiviral agent that reduces virus infectivity can be a useful tool in control programs. Although many compounds with promising in-vitro efficacy have been identified, the lack of laboratory-animal models limited their potential for further clinical development. Recently, we described the activity of type I and III interferons, IFN-α and IFN-λ respectively, against several BVDV strains in-vitro. In this study, we analyzed the in-vivo efficacy of both IFNs using a BALB/c-mouse model. Mice infected with two type-2 BVDV field strains developed a viremia with different kinetics, depending on the infecting strain's virulence, that persisted for 56 days post-infection (dpi). Mice infected with the low-virulence strain elicited high systemic TNF-α levels at 2 dpi. IFNs were first applied subcutaneously 1 day before or after infection. The two IFNs reduced viremia with different kinetics, depending on whether either one was applied before or after infection. In a second experiment, we increased the number of applications of both IFNs. All the treatments reduced viremia compared to untreated mice. The application of IFN-λ pre- and post-infection reduced viremia over time. This study is the first proof of the concept of the antiviral potency of IFN-λ against BVDV in-vivo, thus encouraging further trails for a potential use of this cytokine in cattle. Instituto de Virología Fil: Quintana, María Eugenia. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina. Fil: Barone, Lucas Jose. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina. Fil: Trotta, Myrian Vanesa. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina Fil: Turco, Cecilia. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina Fil: Mansilla, Florencia Celeste. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina Fil: Capozzo, Alejandra Victoria. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina. Fil: Cardoso, Nancy Patricia. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Virología; Argentina. Fil: Quintana, María Eugenia. Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET); Argentina Fil: Barone, Lucas Jose. Consejo Nacional de Investigaciones Científicas y Tecnológicas; Argentina Fil: Capozzo, Alejandra Victoria.Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET); Argentina Fil: Cardoso, Nancy Patricia. Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET); Argentina 2021-01-15T15:11:54Z 2021-01-15T15:11:54Z 2020-02 info:ar-repo/semantics/artículo info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://hdl.handle.net/20.500.12123/8606 https://www.frontiersin.org/articles/10.3389/fvets.2020.00045/full 2297-1769 https://doi.org/10.3389/fvets.2020.00045 eng info:eu-repo/semantics/openAccess application/pdf Frontiers Media Frontiers in veterinary science 7 : 45. (Febrero 2020)
institution INTA AR
collection DSpace
country Argentina
countrycode AR
component Bibliográfico
access En linea
databasecode dig-inta-ar
tag biblioteca
region America del Sur
libraryname Biblioteca Central del INTA Argentina
language eng
topic Bovine Diarrhoea Pestivirus
Interferons
Antiviral Agents
Pestivirus de la Diarrea Bovina
Interferonas
Viricidas
Mouse Model
Modelo de Ratón
Bovine Diarrhoea Pestivirus
Interferons
Antiviral Agents
Pestivirus de la Diarrea Bovina
Interferonas
Viricidas
Mouse Model
Modelo de Ratón
spellingShingle Bovine Diarrhoea Pestivirus
Interferons
Antiviral Agents
Pestivirus de la Diarrea Bovina
Interferonas
Viricidas
Mouse Model
Modelo de Ratón
Bovine Diarrhoea Pestivirus
Interferons
Antiviral Agents
Pestivirus de la Diarrea Bovina
Interferonas
Viricidas
Mouse Model
Modelo de Ratón
Quintana, Maria Eugenia
Barone, Lucas Jose
Trotta, Myrian Vanesa
Turco, Cecilia Soledad
Mansilla, Florencia Celeste
Capozzo, Alejandra
Cardoso, Nancy
In-vivo activity of IFN-λ and IFN-α against bovine-viral-diarrhea virus in a mouse model
description Bovine-viral-diarrhea virus (BVDV) can cause significant economic losses in livestock. The disease is controlled with vaccination and bovines are susceptible until vaccine immunity develops and may remain vulnerable if a persistently infected animal is left on the farm; therefore, an antiviral agent that reduces virus infectivity can be a useful tool in control programs. Although many compounds with promising in-vitro efficacy have been identified, the lack of laboratory-animal models limited their potential for further clinical development. Recently, we described the activity of type I and III interferons, IFN-α and IFN-λ respectively, against several BVDV strains in-vitro. In this study, we analyzed the in-vivo efficacy of both IFNs using a BALB/c-mouse model. Mice infected with two type-2 BVDV field strains developed a viremia with different kinetics, depending on the infecting strain's virulence, that persisted for 56 days post-infection (dpi). Mice infected with the low-virulence strain elicited high systemic TNF-α levels at 2 dpi. IFNs were first applied subcutaneously 1 day before or after infection. The two IFNs reduced viremia with different kinetics, depending on whether either one was applied before or after infection. In a second experiment, we increased the number of applications of both IFNs. All the treatments reduced viremia compared to untreated mice. The application of IFN-λ pre- and post-infection reduced viremia over time. This study is the first proof of the concept of the antiviral potency of IFN-λ against BVDV in-vivo, thus encouraging further trails for a potential use of this cytokine in cattle.
format info:ar-repo/semantics/artículo
topic_facet Bovine Diarrhoea Pestivirus
Interferons
Antiviral Agents
Pestivirus de la Diarrea Bovina
Interferonas
Viricidas
Mouse Model
Modelo de Ratón
author Quintana, Maria Eugenia
Barone, Lucas Jose
Trotta, Myrian Vanesa
Turco, Cecilia Soledad
Mansilla, Florencia Celeste
Capozzo, Alejandra
Cardoso, Nancy
author_facet Quintana, Maria Eugenia
Barone, Lucas Jose
Trotta, Myrian Vanesa
Turco, Cecilia Soledad
Mansilla, Florencia Celeste
Capozzo, Alejandra
Cardoso, Nancy
author_sort Quintana, Maria Eugenia
title In-vivo activity of IFN-λ and IFN-α against bovine-viral-diarrhea virus in a mouse model
title_short In-vivo activity of IFN-λ and IFN-α against bovine-viral-diarrhea virus in a mouse model
title_full In-vivo activity of IFN-λ and IFN-α against bovine-viral-diarrhea virus in a mouse model
title_fullStr In-vivo activity of IFN-λ and IFN-α against bovine-viral-diarrhea virus in a mouse model
title_full_unstemmed In-vivo activity of IFN-λ and IFN-α against bovine-viral-diarrhea virus in a mouse model
title_sort in-vivo activity of ifn-λ and ifn-α against bovine-viral-diarrhea virus in a mouse model
publisher Frontiers Media
publishDate 2020-02
url http://hdl.handle.net/20.500.12123/8606
https://www.frontiersin.org/articles/10.3389/fvets.2020.00045/full
https://doi.org/10.3389/fvets.2020.00045
work_keys_str_mv AT quintanamariaeugenia invivoactivityofifnlandifnaagainstbovineviraldiarrheavirusinamousemodel
AT baronelucasjose invivoactivityofifnlandifnaagainstbovineviraldiarrheavirusinamousemodel
AT trottamyrianvanesa invivoactivityofifnlandifnaagainstbovineviraldiarrheavirusinamousemodel
AT turcoceciliasoledad invivoactivityofifnlandifnaagainstbovineviraldiarrheavirusinamousemodel
AT mansillaflorenciaceleste invivoactivityofifnlandifnaagainstbovineviraldiarrheavirusinamousemodel
AT capozzoalejandra invivoactivityofifnlandifnaagainstbovineviraldiarrheavirusinamousemodel
AT cardosonancy invivoactivityofifnlandifnaagainstbovineviraldiarrheavirusinamousemodel
_version_ 1756007934220828672